Literature DB >> 28059628

Community-wide measles outbreak in the Region of Madrid, Spain, 10 years after the implementation of the Elimination Plan, 2011-2012.

L García Comas1, M Ordobás Gavín1, J C Sanz Moreno2, B Ramos Blázquez2, E Rodríguez Baena3, E Córdoba Deorador3, M García Barquero3, E Gil Montalbán4, A Arce Arnáez1, I Rodero Garduño1, D Barranco Ordóñez5, J Astray Mochales6.   

Abstract

We describe a community-wide outbreak of measles due to a D4 genotype virus that took place in the Region of Madrid, Spain, between February 2011 and August 2012, along with the control measures adopted. The following variables were collected: date of birth, sex, symptoms, complications, hospital admission, laboratory test results, link with another cases, home address, places of work or study, travel during the incubation period, ethnic group, and Mumps-Measles-Rubella (MMR) vaccination status. Incidences were calculated by 100,000 inhabitants. A total of 789 cases were identified. Of all cases, 36.0% belonged to Roma community, among which 68.7% were 16 months to 19 y old. Non-Roma cases were predominantly patients from 6 to 15 months (28.1%) and 20 to 39 y (52.3%). Most cases were unvaccinated. We found out that 3.0% of cases were healthcare workers. The first vaccination dose was brought forward to 12 months, active recruitment of unvaccinated children from 12 months to 4 y of age was performed and the vaccination of healthcare workers and of members of the Roma community was reinforced. High vaccination coverage must be reached with 2 doses of MMR vaccine, aimed at specific groups, such as young adults, Roma population and healthcare workers.

Entities:  

Keywords:  control measures; epidemiology; measles; outbreak; vaccine

Mesh:

Substances:

Year:  2017        PMID: 28059628      PMCID: PMC5443381          DOI: 10.1080/21645515.2016.1267081

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  5 in total

1.  [Outbreaks of Measles in Andalusia, Spain, during the Period 2010-2015].

Authors:  Carmen Montaño Remacha; Virtudes Gallardo García; M Mar Mochón Ochoa; Marcelino García Fernández; José María Mayoral Cortés; Josefa Ruiz Fernández
Journal:  Rev Esp Salud Publica       Date:  2015 Jul-Aug

2.  Current measles outbreak in Greece.

Authors:  T Georgakopoulou; C Grylli; E Kalamara; P Katerelos; G Spala; T Panagiotopoulos
Journal:  Euro Surveill       Date:  2006-02-23

3.  [The State of Measles and Rubella in the WHO European region].

Authors:  Mark Muscat; Myriam Ben Mamou; Abigail Shefer; Dragan Jankovic; Sergei Deshevoy; Robb Butler
Journal:  Rev Esp Salud Publica       Date:  2015 Jul-Aug

4.  Seroprevalence of measles and rubella virus antibodies in the population of the Community of Madrid, 2008-2009.

Authors:  Luis García-Comas; J C Sanz Moreno; M Ordobás Gavín; D Barranco Ordóñez; J García Gutiérrez; B Ramos Blázquez; I Rodero Garduño
Journal:  J Infect Public Health       Date:  2015-05-07       Impact factor: 3.718

5.  The measles outbreak in Bulgaria, 2009-2011: An epidemiological assessment and lessons learnt.

Authors:  Mark Muscat; Lili Marinova; Annette Mankertz; Nina Gatcheva; Zafira Mihneva; Sabine Santibanez; Angel Kunchev; Radosveta Filipova; Mira Kojouharova
Journal:  Euro Surveill       Date:  2016
  5 in total
  4 in total

1.  Indirect costs associated with deaths of children aged 0-14 years from measles in a weak health system and conflict and fragile zone: the case of Somalia.

Authors:  Omar B Da'ar
Journal:  Epidemiol Infect       Date:  2019-08-09       Impact factor: 2.451

2.  Phylogenetic and Epidemiological Analysis of Measles Viruses in Shenzhen, China from January 2015 to July 2019.

Authors:  Min Lei; Kai Wang; Jing Li; Yan Zhang; Xuemei Wei; Lifeng Qi; Gaofeng Zhou; Yue Wu
Journal:  Med Sci Monit       Date:  2019-12-04

3.  Measles epidemic in pediatric population in Greece during 2017-2018: Epidemiological, clinical characteristics and outcomes.

Authors:  Maria Gianniki; Tania Siahanidou; Evanthia Botsa; Athanasios Michos
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.240

4.  Case report: Ribavirin and vitamin A in a severe case of measles.

Authors:  Amandine Bichon; Camille Aubry; Lucas Benarous; Hortense Drouet; Christine Zandotti; Philippe Parola; Jean-Christophe Lagier
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.